Table 4

All-cause PPPM healthcare costs among Medicaid beneficiaries with HCV and ALD (cases) and matched patients with HCV and no ALD (comparison)
Patients with HCV and ALD (Cases) Patients with HCV and without ALD (Comparison) Difference P-value1
N 1193 1193
Inpatient
Mean (SD) $2,649 ($4,179) $337 ($981) $2,312 < .001
Median $905 $0
IQR $0-$3,430 $0-$79
Outpatient2
Mean (SD) $713 ($824) $215 ($320) $498 < .001
Median $467 $132
IQR $249-$902 $49-$270
Pharmacy
Mean (SD) $791 ($1,401) $818 ($1,312) -$27 0.032
Median $385 $462
IQR $126-$895 $132-$1,029
Other costs3
Mean (SD) $784 ($1,541) $360 ($1,265) $424 < .001
Median $171 $90
IQR $51-$669 $18-$208
Total costs
Mean (SD) $4,937 ($5,236) $1,730 ($2,309) $3,207 < .001
Median $3,146 $1,002

Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.

Notes: All costs are inflated to 2009 USD using the Medical Care component of the CPI. Costs over the entire follow-up period were divided by the number of eligible patient months to create the PPPM cost estimates.

1Calculated with the Wilcoxon test for comparison of means.

2Patients may have received multiple outpatient services on the same day, including hospital outpatient, physician, nurse practitioner, physician assistant, clinic, or other outpatient services.

3 "Other" costs include nursing home, home health, hospice, and other services.

ALD advanced liver disease, HCV hepatitis C virus, PPPM per-patient-per-month.

Menzin et al.

Menzin et al. BMC Health Services Research 2012 12:459   doi:10.1186/1472-6963-12-459

Open Data